谷氨酸转运体、谷氨酸/胱氨酸转运体与谷氨酸神经细胞毒作用

摘要/Abstract

摘要： 谷氨酸转运体与谷氨酸/胱氨酸转运体在脑缺血疾病中起重要作用,谷氨酸转运体的结构或功能改变可使细胞间隙的谷氨酸浓度急剧升高,激活NMDA 受体产生一系列的表现,同时抑制谷氨酸/胱氨酸转运体对胱氨酸的摄取,介导谷胱苷肽耗竭、氧自由基升高、胞内钙升高、线粒体损伤、细胞色素c释放等神经细胞毒环节,激活半胱天冬酶诱导凋亡。可进一步加重谷氨酸的神经细胞毒作用。

关键词: 药理学, 综述, 谷氨酸, 谷氨酸转运体, 谷氨酸胱氨酸转运体, 神经毒性

Abstract: ThisPaper introduces the relationshiPbetween glutamate transporter,glutamate/cysteine transporter and neurotoxicity induced by glutamate.UnderPathologic conditions,glutamate transporters release glutamate to activate glutamate receptors,and inhibit the uptake of glutamate/cysteine transporters,which induces downstream changes.Among these changes oxygen-derived free radidicals affects the function of glutamate transporter and enhances the neurotoxicity of glutamate.All these canlead to neurocyte death.Glutamate transporters release glutamate to inhibit the uptake of glutamate/cysteine transpoter and activate glutamate receptor.The inhibition of glutamate/cysteine transpoter affects the function of glutamate transporter.Two transporters interaction and the downstream changeslead to neurocytes death.

Key words: pharmacology, reviews, glutamate transporter, glutamate/cysteine transporter, neurotoxicity

中图分类号:

R338.2

虞希冲, 朱桐君. 谷氨酸转运体、谷氨酸/胱氨酸转运体与谷氨酸神经细胞毒作用[J]. 中国临床药理学与治疗学, 2003, 8(5): 490-493.

YU Xi-Chong, ZHU Tong-Jun. RelationshiPbetween glutamate transporter , glutamate/cysteine transporter and neurotoxicity induced by glutamate[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(5): 490-493.

参考文献

1 Takahshi M,Billups B,Rossi D,et al.The role of glutamate transporters in glutamate homeostasis in the brain[J].J ExPBiol,1997;200:401-9
2 Jabauon D,Scanziani M,Gahwiler BH,et al.Acute decrease in net glutamate uptake during energy deprivation[J].Proc Natl Acad Sci UAS,2000;97:5610-5
3Pillis JW,Ren J,O' Regan MH.Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex:studies with DL-threo-beta-benzyloxyaspartate[J].Brain Res,2000;868:105-12
4 Seki Y,FeustelPJ,Keller RW Jr,et al.Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker[J].Stroke,1999;30:433-40
5 Douen AG,Akiyama K,HoganMJ,et al.Preconditioning with cortical spreading depression decreases intraischemic cerebrallutamatelevels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebral cortexPlasma membranes[J].J Neurochem,2000;75:812-8
6 Griffith OW.Biologic andPharmacologic regulation of maintain glutathione synthesis[J].Free Radic boilMed,1999;27:922-35
7Piani D,Fontana A.Involvement of the cy stine transport system Xc-in macrophage-induced glutamate-dependent cytotoxicity to neurons[J].J Immunol,1994;152:3578-85
8 Shanker G,Aschner M.Identification and characterization of uptake systems for cystine and cysteine in culture astrocytes and neurons:Evidence for methylmercury-targeted disruption of astrocyte transport[J].J Neurosci Res,2001;166:998-1002
9 McBean GY,Flynn J.Molecular mechanisms of cystine transport[J].Biochem Soc Trans,2001;29:717-22
10 Schubert D,Piaseki D.Oxidative glutamate toxicity can be a component of the excitotoxicity cascade[J].J Neurosci,2001;21:7455-62
11 Trotti D,Danbolt NC,Voltena A.Glutamate transporters are oxidant-vulnerable:a molecularlink between oxidative and exictoxic neurodegeneration[J] ?TrendsPharmacol Sci,1998;19:328-34
12 Ratan RR,Baraban JM.Apoptotic death in vitro model of neuronal oxidative sress[J].Clin ExpPhamarcolPhysiol,1995;42:309-10
13 Cho ES,Johnson N,Suider BC.Tissue glutathione as reservoir during cyst(e)ine depletion in growing rats[J].J Nutr,1984;114:1853-62
14 MartinM,MaciasM,Escames G,et al.Melatonin but not vitC and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial or oxidative stress[J].J FASEB,2000;14:1677-9
15 Han D,Sen CK,Roy S,et al.Protection against glutamateinduced cytotoxicity in C6 glial cells by thiol antioxidants[J].Am JPhy siol,1997;273:R1771-8
16 Tan S,Sagara Y,Liu Y,et al.The regulation of reactive oxygen speciesProduction duringProgrammed cell dath[J].J Cell Biol,1998;141:1423-32
17Perez Velazquez JL,Frantseva MV,CarlenPL.In vitro ischemiaPromotes glutamate-induced free radical generation and intracellular calcium accumulation in hippocampalPyramidal neurons[J].J Neurosci,1997;17:9085-94
18 Schinder AF,Olson EC,Spitzer NC,et al.Mitochondrial dysfunction is aPrimary event in glutamate neurotoxicty [J].J Neurosci,1996;16:6125-33
19 Hunter DR,Haworh RA,Southard JH.RelationshiPbetween configuration,function andPermeability in calcium-treated mitochondria[J].J Biol Chem,1976;251:5069-77
20 Yoshimura S,Banno Y,Takenaka K,et al.Ceramide formationleads to caspase-3 activation during hypoxicPC12 cell death:inhibitory effects of bcl-2 on ceramide formation and caspase-3 activation[J].J Biol Chem,1998;273:6921-7
21 Yoshimura S,Banno Y,Nakashima S,et al.Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxicPC12 cell death [J].J Neurochem,1999;73:675-83
22 Zhivotovsky B,Orrenius S,Brastugun OT,et al.Injected cytochrome c induces apoptosis[J].Nature,1998;391:449-50
23 Yang J,Liu X,Bhalla K,et al.Prevention of apoptosis by bcl-2:release of cytochrome c from mitochondria blocked[J].Science,1997;275:1129-32
24 Kluck RM,Bossy-Wetzel E,Green DR,et al.The release of cytochrome c from mitochondria:APrimary site for bcl-2 regulation of apoptosis[J].Science,1997;275:1132-6
25 Kirkland RA,Franklin JL.Evidence for redox regulation of cytochrome c release duringProgrammed neuronal death:Antioxidant effects ofProtein synthesis and caspase inhibition[J].J Neurosci,2001;21:1949-63
26 ZhangP,Liu B,Kang SW,et al.ThioredoxinPeroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of bcl-2[J].J Biol Chem,1997;272:30615-8
27 Baek SH,Kim JY,Choi JH,et al.Reduced glutathione oxidation ratio and 8ohG accumulation by mild ischemicPretreatment[J].Brain Res,2000;856:28-36
28 Schulz JB,Weller M,Moskowtz MA.Caspases as treatment targets in stroke and neurodegenerative diseases[J].Ann Neurol,1999;45:421-9
29 Hirashima Y,Kurimoto M,Nosami K,et al.Correlation of glutamate-induced apoptosis with caspase activaties in cultural cortical neurons[J].Brain Res,1999;849:109-18

[1]	游蓉丽, 黄玉荣, 毛睿, 海丽娜, 王颖莉, 王艳. 基于血清代谢组学与网络药理学探究复方苦参注射液治疗肺癌的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(9): 988-999.
[2]	胡康一, 曹林忠, 万超超, 尚征亚, 杨小瑞, 张勇杰. 基于线粒体功能障碍探讨中药防治激素性股骨头坏死的基础研究进展[J]. 中国临床药理学与治疗学, 2023, 28(6): 688-696.
[3]	曹放, 覃开蓉, 郑国爽, 赵德伟. 基于网络药理学探讨银杏叶干预激素性股骨头坏死的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(3): 266-275.
[4]	马广立, 张菁. 定量药理学在疫苗研发中应用的概述与展望[J]. 中国临床药理学与治疗学, 2023, 28(3): 315-322.
[5]	侯小煜, 冷玉芳, 曹雪芬, 吕兴娇, 韩晓霞, Janvier NIBARUTA, 刘永强. 五味子乙素减轻小鼠肠缺血再灌注损伤的网络药理学分析及实验验证[J]. 中国临床药理学与治疗学, 2023, 28(2): 147-154.
[6]	刘璐, 石雨菲, 何庆烽, 徐凤艳, 王鲲, 蔡卫民, 相小强. 群体模型分析方法评估基因多态性对药物PK/PD的影响[J]. 中国临床药理学与治疗学, 2023, 28(11): 1275-1282.
[7]	陈玉林, 蒋虎刚, 王新强, 刘凯, 李应东, 安涛, 赵信科. 基于网络药理学和分子对接探讨芪参益心颗粒治疗射血分数保留型心力衰竭的作用机制[J]. 中国临床药理学与治疗学, 2023, 28(10): 1081-1092.
[8]	高丽丽, 王玉珠, 王燕, 李健, 王骏. 抗肿瘤抗体偶联药物临床药理学研究的若干问题与考虑[J]. 中国临床药理学与治疗学, 2023, 28(1): 75-85.
[9]	刘艳之, 王艳, 刘凯丽, 周文华, 朱平, 王颖莉, 杜守颖. 西黄丸对H22荷瘤小鼠的抑瘤作用及其机制研究[J]. 中国临床药理学与治疗学, 2022, 27(7): 754-761.
[10]	姚倩, 陈赟, 商娟, 袭晓昀, 陈影, 顾潇, 居文政, 邹建东, 卢苏, 许美娟. 基于HPLC-Q-TOF/MS和网络药理学的清心滋肾方防治绝经综合征潜在药效物质基础和作用机制研究[J]. 中国临床药理学与治疗学, 2022, 27(5): 481-497.
[11]	于泽芳, 范理菊, 尹晓玉, 高丽丽, 董占军. 新型速效抗抑郁药的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(5): 595-600.
[12]	张凝之, 赵玉红, 唐敏娜, 张泳巧, 宁思思, 崔兆强. 时辰药理学在高血压治疗中的应用[J]. 中国临床药理学与治疗学, 2022, 27(4): 418-422.
[13]	谢梦蝶, 王衬衬, 李冰涛, 欧阳长生, 邱雨美, 李洪铭, 涂珺, 尚广彬, 汤喜兰. 基于体外细胞实验和网络药理学研究乳香挥发油抗心脏肥大的作用机制[J]. 中国临床药理学与治疗学, 2022, 27(3): 241-252.
[14]	樊迪, 史翠娜, 杨青青, 纪木火. 七氟烷麻醉对发育期大脑影响的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(12): 1333-1339.
[15]	杨柳, 罗爱林, 李世勇. 全麻药物损伤发育期大脑的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(12): 1381-1390.